Therefore, PD-L1 antibody exerts its functions through immune cells different from that of the PD-1 antibody, i.e., blocking PD-L1 not only reduces the inhibition of T cells, but also elicits an anti-tumor response through other immune cells. The gene discussed is PDCD1; the disease is neoplasm.